The research showed that in the mouse models, HER2-CAR NK -92 cells (2nd generation CAR, CD28) could specifically recognize and kill HER2+ glioblastoma cells and induce endogenous anti-tumor immunity. The gene discussed is ERBB2; the disease is glioblastoma.